Skip to content

Guardant Health Inc Sustainability Reports

Guardant Health, Inc. is a precision oncology company that develops and commercializes advanced blood and tissue tests, real-world data, and AI analytics. Their liquid biopsy tests improve patient outcomes by enabling early cancer screening, monitoring recurrence, and selecting treatments for advanced cancer.

Sector: Healthcare & social services

Country: United States

Exchange: Nasdaq

LEI: 254900M8C3E5VC8BR186

FIGI: BBG006D97VZ8

12 reports from 2018 to 2025